Vasectomy News and Research

RSS

A vasectomy is a surgical procedure that makes a man sterile, or unable to get a woman pregnant. It is generally considered to be at least as effective as female sterilization and is simpler to perform, safer, and less costly. A vasectomy is done by blocking the tube, called the vas deferens, through which sperm normally pass from each testicle on the way to the seminal vesicle, forming semen.

Home-based semen analysis kit could provide rapid, cost-effective way to test male fertility

It is estimated that of the 70 million cases of infertility worldwide, almost half are caused by factors relating to the male partner. A number of semen parameters – motility, morphology, velocity, volume, concentration, and count – affect male fertility.

28 Feb 2018

Maryland offers many insured men free vasectomy coverage

It was a well-intentioned effort to provide men with some of the same financial protection from birth control costs that women get. But a new Maryland law may jeopardize the ability of thousands of consumers — both men and women — to use health savings accounts.

13 Feb 2018

Birth control method for men by gene editing

Researchers at the Michigan State University have come closer to finding an effective method of male contraception. Men have been notorious in not choosing to be responsible of their fertility and not adopting contraception.

12 Oct 2017

Prostate cancer screening reduces cancer deaths finds new analysis

There has been much debate regarding the utility of prostate cancer screening in reducing the rates of deaths due to this cancer among men. While the ERSPC (European Randomized Study of Screening for Prostate Cancer) suggests that screening reduced prostate cancer deaths, the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found that regular screening does not reduce the cancer death rates in prostate cancer. Researchers thus looked at the actual picture as to which of these – ERSPC or PLCO are correct.

5 Sep 2017

Reducing DVT and leg ulcers through personalized compression socks

Professor Charles McCollum, who heads up the vascular studies unit, is a research vascular surgeon, and he developed four-layer bandaging technique, which is the gold standard treatment for healing up leg ulcers by compression.

5 Jul 2017

Male contraceptive proves effective at preventing pregnancy amongst monkeys

Treating male monkeys with the contraceptive Vasalgel has proved effective at preventing conception amongst rhesus monkeys, reports the California National Primate Research Center. The report is based on findings from a study that involved sixteen rhesus monkeys that were treated with the contraceptive...

9 Feb 2017

Men have positive attitude towards new male contraceptive, study finds

A new study has found that men have positive attitudes towards an innovative male contraceptive, Vasalgel. The landmark study, published in Cogent Medicine, is the first insight into how men perceive the new contraceptive and gives promising signs that Vasalgel may revolutionise approaches to reproductive health.

2 Nov 2016

Revised prostate cancer guidelines did not reduce usage of PSA tests, study finds

Controversy over prostate cancer screening guidelines that discourage use of PSA tests did not significantly reduce use of the test, a five-year review of more than 275,000 visits at UT Southwestern Medical Center showed.

6 Oct 2016

New study shows female urologists perform more surgeries on women than male counterparts

Although female certified urologists are still a minority within the specialty, they perform many more procedures on women than their male colleagues, who perform more procedures on men than their female colleagues.

17 Aug 2016

UCLA urologist debunks 5 common myths about vasectomies

Men can be very concerned about what happens during, and after, a vasectomy - specifically how it will affect them personally. Dr. Jesse Mills, a clinical professor of urology and director of The Men's Clinic at UCLA, says the many myths surrounding the procedure can make men rethink what is often a smart choice for them.

20 Jul 2016

Age, race and family history are the biggest risk factors for prostate cancer, new research suggests

New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and vasectomy also add to the risk. In contrast, obesity, alcohol abuse, and smoking show a negative association with the disease.

30 Sep 2015

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis today announced the US Food and Drug Administration has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

25 Jul 2015

MES announces worldwide release of new automated sperm quality analyzer

Medical Electronic Systems today announced the worldwide release of the SQA-Vision, the company's new automated sperm quality analyzer. The SQA-Vision was developed based on 10 years of market feedback and is positioned to augment the company's line of SQA-V and QwikCheck semen analyzers with a top of the line solution.

17 Jul 2015

Robert B. Kiningham receives Founders' Award at 2015 AMSSM Annual Meeting

Robert B. Kiningham, MD, was awarded the Founders' Award at the 24th American Medical Society for Sports Medicine Annual Meeting in Hollywood, Fla. The award is bestowed when AMSSM leadership determines that a member exemplifies the best that a sports medicine physician can be and do.

16 Apr 2015

Vasectomy associated with small increased risk of prostate cancer

Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer according to a new study from Harvard School of Public Health.

10 Jul 2014

Chesapeake Urology for Kids introduced for pediatric care

Chesapeake Urology Associates, PA, the premier urology practice in Maryland and the Mid-Atlantic region, introduces Chesapeake Urology for Kids, a comprehensive program to treat urologic conditions in children from pre-natal to 18 years of age. This new division is being led by Robert Mevorach, MD, a fellowship trained pediatric urologist. An office exclusively for pediatric patients is now open at 25 Crossroads Drive in Owings Mills, Maryland.

31 Jan 2014

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) today announced that results from two studies of REVLIMID (lenalidomide) combinations in patients with diffuse large B-cell lymphoma (DLBCL) were presented at the American Society of Hematology annual meeting in New Orleans, La.

11 Dec 2013

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.

18 Jul 2013

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that its phase III study (MM-020/IFM 07-01) of REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma met its primary endpoint of progression-free survival.

11 Jul 2013

Adverse fetal growth, exposure to maternal smoking correlated with lower measures of sperm quality

Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.

8 Jul 2013